Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives

by Veronique Promelle, Vincent Goeb, Julie Gueudry
Published 2021-05-01

Bone Remodelling Markers in Rheumatoid Arthritis

by Patrice Fardellone, Alice Séjourné, Julien Paccou, Vincent Goëb
Published 2014-01-01

Biomarkers in Rheumatoid Arthritis

by Vincent Goëb, Patrice Fardellone, Jean Sibilia, Frédérique Ponchel
Published 2014-01-01

Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review

by Patrice Fardellone, Emad Salawati, Laure Le Monnier, Vincent Goëb
Published 2020-10-01

Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life

by Valentine Deprez, Laure Le Monnier, Jean-Marc Sobhy-Danial, Franck Grados, Isabelle Henry-Desailly, Sarah Salomon-Goëb, Thibault Rabin, Sanja Ristic, Mathurin Fumery, Patrice Fardellone, Vincent Goëb
Published 2020-10-01

Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network

by Jean-Hugues Salmon, Jean-Guillaume Letarouilly, Vincent. Goëb, Lukshe Kanagaratnam, Pascal Coquerelle, Marie-Hélène Guyot, Eric Houvenagel, Nicolas Lecuyer, Laurent Marguerie, Gauthier Morel, Guy. Baudens, Elisabeth Gervais, René-Marc Flipo
Published 2020-05-01

High-Grade Salivary-Gland Involvement, Assessed by Histology or Ultrasonography, Is Associated with a Poor Response to a Single Rituximab Course in Primary Sjögren's Syndrome: Data...

by Divi Cornec, Sandrine Jousse-Joulin, Sebastian Costa, Thierry Marhadour, Pascale Marcorelles, Jean-Marie Berthelot, Eric Hachulla, Pierre-Yves Hatron, Vincent Goeb, Olivier Vittecoq, Emmanuel Nowak, Jacques-Olivier Pers, Valérie Devauchelle-Pensec, Alain Saraux
Published 2016-01-01

Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch Study

by Jean Darloy, Nicolas Segaud, Jean-Hugues Salmon, Jean-Paul Eschard, Vincent Goëb, Xavier Deprez, Marie-Hélène Guyot, Eric Houvenagel, Nicolas Lecuyer, Laurent Marguerie, Samuel Gally, David Pau, Isabelle Idier, Guy Baudens, René-Marc Flipo
Published 2019-01-01

Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the...

by Jacques-Eric Gottenberg, Raphaèle Seror, Corinne Miceli-Richard, Joelle Benessiano, Valerie Devauchelle-Pensec, Philippe Dieude, Jean-Jacques Dubost, Anne-Laure Fauchais, Vincent Goeb, Eric Hachulla, Pierre Yves Hatron, Claire Larroche, Véronique Le Guern, Jacques Morel, Aleth Perdriger, Xavier Puéchal, Stephanie Rist, Alain Saraux, Damien Sene, Jean Sibilia, Olivier Vittecoq, Gaétane Nocturne, Philippe Ravaud, Xavier Mariette
Published 2013-01-01

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?

by Valérie Devauchelle-Pensec, Jacques-Eric Gottenberg, Sandrine Jousse-Joulin, Jean-Marie Berthelot, Aleth Perdriger, Eric Hachulla, Pierre Yves Hatron, Xavier Puechal, Véronique Le Guern, Jean Sibilia, Laurent Chiche, Vincent Goeb, Olivier Vittecoq, Claire Larroche, Anne Laure Fauchais, Gilles Hayem, Jacques Morel, Charles Zarnitsky, Jean Jacques Dubost, Philippe Dieudé, Jacques Olivier Pers, Divi Cornec, Raphaele Seror, Xavier Mariette, Emmanuel Nowak, Alain Saraux
Published 2015-01-01